SEPRACOR INC.
Patent Owner
Stats
- 94 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 21, 2014 most recent publication
Details
- 94 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,702 Total Citation Count
- Oct 11, 1985 Earliest Filing
- 260 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7816375 Ligands for monoamine receptors and transporters, and methods of use thereofMar 12, 09Oct 19, 10[A61K, C07D, A61P]
7714023 Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolitesFeb 17, 05May 11, 10[A61K, A01N, C07D]
7671087 Amines that inhibit a mammalian anandamide transporter, and methods of use thereofFeb 25, 09Mar 02, 10[A61K, C07D, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7692019 Methods for the stereoselective synthesis of substituted piperidinesExpiredFeb 28, 06Apr 06, 10[C07D]
2009/0111,818 Combinations of Eszopiclone and O-Desmethylvenlafaxine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive DisordersAbandonedJul 05, 06Apr 30, 09[A61K]
2009/0035,224 Methods of Using Albuterol and Calcium Activated Potassium Channel OpenersAbandonedJun 14, 05Feb 05, 09[A61K, A61P]
2008/0293,726 Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive DisordersAbandonedJul 06, 06Nov 27, 08[A61K, C07C, A61P]
2008/0293,788 Methods and Compositions for the Treatment of Pulmonary DiseasesAbandonedJun 14, 05Nov 27, 08[A61K, A61P]
2008/0234,247 Heterocyclic analgesic compounds and methods of use thereofAbandonedMar 17, 08Sep 25, 08[A61K, C07D, A61P]
2008/0221,072 Fatty Acid Modified Forms of GlucocorticoidsAbandonedMay 15, 08Sep 11, 08[A61K, A61P, C07J]
2008/0058,395 Fused heterocyclic inhibitors of D-amino acid oxidaseAbandonedJul 02, 07Mar 06, 08[A61K, C07D, A61P]
2007/0282,007 TREATMENT OF PAIN DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE AND ITS FORMAMIDEAbandonedMar 30, 07Dec 06, 07[A61K, A61P]
2007/0225,331 4,4-Disubstituted piperidines, and methods of use thereofAbandonedMay 14, 07Sep 27, 07[A61K, C07D]
2007/0203,111 Cycloalkylamines as monoamine reuptake inhibitorsAbandonedJan 05, 07Aug 30, 07[A61K, C07D]
7064138 Methods for treating irritable bowel syndrome using optically pure (-) norcisaprideExpiredFeb 26, 03Jun 20, 06[A61K]
2006/0128,993 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideAbandonedJan 24, 06Jun 15, 06[C07C]
2006/0079,489 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadineAbandonedDec 02, 05Apr 13, 06[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.